Nate B.

Nate B. is the VP and Head of Late Development Statistics at UCB, specializing in Biostatistics and Quantitative Sciences. With extensive experience across various therapeutic areas including immunology and oncology, Nate has engaged in submission and regulatory interactions with the FDA. Nate has previously held senior positions at Boehringer Ingelheim, Roivant Family of Companies, and Allergan, and has demonstrated effective leadership by managing teams of over 30 individuals. An accomplished communicator, Nate excels in translating complex statistical concepts into accessible language and has been actively involved in mentoring and training.